Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Clinical and Experimental Rheumatology|June 24, 2020
Fluorinated steroids are not superior to any treatment to ameliorate the outcome of autoimmune mediated congenital heart block: a systematic review of the literature and meta-analysisAriela Hoxha, Elena Mattia, Anna Zanetti, et al.
Lupus|November 17, 2020
Pulmonary hypertension associated with congenital heart block and neonatal lupus syndrome: A series of four casesAlice Maltret, Nathalie Morel, Marilyne Levy, et al.
The Journal of Biological Chemistry|December 25, 2004
Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cellsCécile Féraudet, Nathalie Morel, Stéphanie Simon, et al.
Carbohydrate Research|December 25, 2007
Synthesis of an anthrose derivative and production of polyclonal antibodies for the detection of anthrax sporesSandrine G Y Dhénin, Vincent Moreau, Nathalie Morel, et al.
Autoimmunity Reviews|June 20, 2013
Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximabHoracio Berman, Ignasi Rodríguez-Pintó, Ricard Cervera, et al.
Fetal Diagnosis and Therapy|December 9, 2020
Longitudinal Analysis of Fetal Ventricular Rate for Risk Stratification in Immune Congenital Heart BlockAyla Shokrzadeh, Alice Maltret, Nathalie Morel, et al.
Presse Medicale (Paris, France : 1983)|September 13, 2016
[2016 review on catastrophic antiphospholipid syndrome]Nathalie Costedoat-Chalumeau, Laetitia Coutte, Véronique Le Guern, et al.
Best Practice & Research. Clinical Rheumatology|November 19, 2013
Adherence to treatment in systemic lupus erythematosus patientsNathalie Costedoat-Chalumeau, Jacques Pouchot, Gaëlle Guettrot-Imbert, et al.
Plos One|August 8, 2013
A simple and fast non-radioactive bridging immunoassay for insulin autoantibodiesIngrid Kikkas, Roberto Mallone, Nadia Tubiana-Rufi, et al.
The Journal of Biological Chemistry|May 14, 2004
Selective and efficient immunoprecipitation of the disease-associated form of the prion protein can be mediated by nonspecific interactions between monoclonal antibodies and scrapie-associated fibrilsNathalie Morel, Stéphanie Simon, Yveline Frobert, et al.
Pageof 9